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a b s t r a c t
Acute pancreatitis is a common disorder in the USA. Its diagnosis, prognosis and management, both in the short and long term, have long presented
signiﬁcant challenges to clinicians, surgeons, and diagnostic and interventional radiologists. This article reviews historical and current concepts in the
diagnosis and management of acute pancreatitis and its complications, including radiological diagnosis and percutaneous intervention, as well as
endoscopic and surgical management.
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Acute pancreatitis is a common disorder in the USA, with more
than 200,000 hospital admissions each year for management of the
disease.1 Acute pancreatitis in its many forms often presents com-
plex diagnostic and management challenges to physicians, sur-
geons, and radiologists caring for patients with the disease. In this
article we discuss current practices in the diagnosis and manage-
ment of acute pancreatitis.Diagnosis and severity assessment of acute pancreatitis
Clinical diagnosis of acute pancreatitis is based on patient
symptoms, physical examination, laboratory analysis, and radio-
logical data. According to practice guidelines published in 2006, a
diagnosis of acute pancreatitis requires two out of three main
features: (1) abdominal pain typical for acute pancreatitis, (2)
serum amylase and/or lipase greater than or equal to three times
the upper normal limit; and (3) evidence of acute pancreatitis on
computed tomography (CT) scans.1
Almost all patients with acute pancreatitis have acute upper
abdominal pain at onset. The pain is usually severe and constant.
The pain may be conﬁned to the mid-epigastrium or may be diffuse
throughout the abdomen. Approximately half of patients report
pain that radiates to the back that may be relieved by sitting or
leaning forward. Patients frequently experience nausea and vom-
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ranging from biliary colic, gastric or duodenal ulcer perforation and
bowel obstruction, to mesenteric ischemia, aortic aneurysm or
dissection, and even inferior wall myocardial infarction.1
Physical signs and symptoms often depend on the severity of
the attack. Systemic features include fever and tachycardia, and in
severe cases patients may be in shock. In mild disease, the epi-
gastrium may be minimally tender on physical examination,
whereas patients with severe pancreatitis may have abdominal
distention, tenderness, and guarding. Jaundice can occur due to
obstruction of the common bile duct secondary to chol-
edocholithiasis or due to extrinsic compression of the common bile
duct due to edema within the pancreas head.
Laboratory analysis for work-up of patients with signs and
symptoms of acute pancreatitis includes serum amylase and lipase
levels, as well as a complete blood count, electrolytes, blood urea
nitrogen (BUN), creatinine, liver function tests, and inﬂammatory
markers, such as C reactive protein (CRP). In a recent retrospective
analysis, the sensitivity and speciﬁcity for lipase levels in the
diagnosis of acute pancreatitis were 96.6% and 99.4%, respectively.
The sensitivity and speciﬁcity of amylase levels in diagnosing acute
pancreatitis were 78.6% and 99.1%, respectively.2 An elevated serum
amylase level is less speciﬁc as it can also occur in a number of other
conditions aside from acute pancreatitis, including diseases of the
salivary glands, cholecystitis, bowel obstruction or ischemia, and
peptic ulcer disease. In addition, the longer half-life of lipase in
comparison to amylase makes it a useful diagnostic measure inedical School, Worcester, MA, USA
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Table 2 Revised Atlanta Classiﬁcation4
Disease severity Symptoms
Mild acute pancreatitis No organ failure
No local or systemic complications
Moderately severe
acute pancreatitis
Organ failure that resolves within
48 h (transient organ failure)
Local or systemic complications
without persistent organ failure
Severe acute pancreatitis Persistent organ failure (>48 h)
Single organ failure
Multiple organ failure
Table 3 Ranson’s Criteria5
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have already returned to normal. The level of pancreatic enzyme
elevation does not correlate with the severity of the disease, and
serial measurements should not be used as a tool to assess the
prognosis or progress of acute pancreatitis. However, it has been
noted that CRP levels >150 mg/dL at 48 hours help to differentiate
between severe and mild disease.2
Initial assessment of severity is one of themost important issues
in the management of acute pancreatitis. Approximately 15–20% of
patients with acute pancreatitis will develop severe disease
resulting in a prolonged clinical course, often in the setting of
pancreatic parenchymal necrosis. An international symposium held
in Atlanta, Georgia, in 1992, established a clinically based classiﬁ-
cation system for acute pancreatitis (Table 1).3 The revised Atlanta
classiﬁcation of acute pancreatitis established in 2008 identiﬁes
two phases of the disease: early and late.4 Severity is classiﬁed as
mild, moderate, or severe (Table 2). Mild acute pancreatitis, the
most common form, has no organ failure or local or systemic
complications and usually resolves in the ﬁrst week. Moderately
severe acute pancreatitis is deﬁned by the presence of transient
organ failure, local complications, or exacerbation of co-morbid
disease. Severe acute pancreatitis is deﬁned by persistent organ
failure lasting longer than 48 hours.4
A variety of predictive systems have been developed to assist
clinicians in predicting prognosis. These include Ranson’s criteria
(Table 3), APACHE II (Acute Physiology and chronic Health Evalua-
tion), and the BISAP (Bedside Index for Severity in Acute Pancrea-
titis) score.5–7 Of these, the BISAP score represents a simple way to
identify patients at risk of increasedmortality and the development
of intermediate markers of severity within 24 hours of presenta-
tion. The BISAP score provides a single point for each of ﬁve pa-
rameters: BUN > 25 mg/dL, impaired mental status, systemic
inﬂammatory response syndrome (SIRS), age> 60 years, and/or the
presence of a pleural effusion, for a possible total of ﬁve points. A
BISAP score greater than three is associated with a seven- to 12-fold
increase in the risk of developing organ failure (Table 4).7 Hemo-
concentration, indicated by an admission hematocrit of 47%, and
subsequent failure of the hematocrit to decrease by 24 hours are
risk factors for the development of pancreatic necrosis.8 Older age
(55 years) and a body mass index (BMI) 30 are also known risk
factors formore severe forms of pancreatitis. In particular, obesity is
associated with increased risk of developing both systemic and
local complications.9 However, according to a recent large
population-based study, abdominal adiposity, rather than total
body fat, places patients at particular risk.10
Role of imaging in diagnosis
The Atlanta classiﬁcation ﬁrst reported in 1992 and its revision
in 2008 provide a radiographic classiﬁcation system for standard-
ized diagnosis and management of acute pancreatitis.3 The revisedTable 1 Atlanta Criteria for Severity3 (Early Prognostic Signs: Ranson’s
Score ‡3; APACHE II Score ‡8)
Feature Symptoms
Organ failure Shock (systolic blood pressure < 90 mmHg)
Pulmonary insufﬁciency (PaO2 < 60 mmHg)
Renal failure (serum creatinine >2 mg/dL after rehydration)
Gastrointestinal bleeding (>500 mL/24 h)
Local
complications
Pancreatic necrosis (>30% of the parenchyma or >3 cm)
Pancreatic abscess (circumscribed collection of
pus containing little or no pancreatic necrosis)
Pancreatic pseudocyst (collection of pancreatic
juice enclosed by a wall of ﬁbrous tissue or
granulation tissue)imaging classiﬁcation system reﬂects advances in knowledge of the
disease process and in radiologic techniques since the original
classiﬁcation scheme.11 The ultimate aim of the Atlanta classiﬁca-
tion is to provide a consistent radiographic lexicon for more precise
communication of the severity and complications of acute
pancreatitis to clinicians responsible for clinical management of
patients.
Contrast-enhanced multi-detector CT (CECT) is the primary
imaging modality used for further evaluation when acute pancre-
atitis is suspected or diagnosed clinically. Its speed and reproduc-
ibility, as well as its ability to accurately demonstrate morphologic
changes in acute pancreatitis, make it an ideal ﬁrst step in imaging
of patients with acute pancreatitis. The main drawback of CT is its
use of ionizing radiation, especially for younger patients who may
require several repeat scans over the course of their illness. What
remains somewhat unclear is the best time frame in which to
perform CT after the patient’s initial presentation. It is generally
accepted that early in the course of the disease, the clinical severity
and morphologic characteristics seen on CT may not directly
correlate with each other. Imaging too early, before 48 hours, may
signiﬁcantly underestimate disease severity on the basis of imaging
characteristics.12,13 In general, CT is not indicated in patients who
are clinically classiﬁed as having mild pancreatitis (no clinical signs
of severe pancreatitis) and show rapid improvement with appro-
priate medical management. CT should be used in patients who are
classiﬁed as having severe pancreatitis or are at risk of developing
severe pancreatitis, ideally after 72 hours, to best assess the full
extent of the disease.12 In addition, while generally not used for
evaluation of the pancreas itself, ultrasound (US) is often performed
early in the course of the disease, regardless of the severity, to help
establish an etiology for the pancreatitis (i.e. the presence of
cholelithiasis or choledocholithiasis) and direct the need for further
endoscopic or surgical management [endoscopic retrograde chol-
angiopancreatography (ERCP) or cholecystectomy].13
The revised Atlanta classiﬁcation subdivides acute pancreatitis
into two types: interstitial edematous pancreatitis (IEP) andCriterion Non-gallstone
pancreatitis
(1974)
Gallstone
pancreatitis
(1982)
On admission
Age (y) >55 >70
White blood cells (/mm3) >16,000 >18,000
Blood glucose (mg/dL) >200 >220
Serum lactate dehydrogenase (IU/L) >350 >400
Serum aspartate aminotransferase (IU/L) >250 >250
During initial 48 h
Hematocrit decrease (%) >10 >10
Blood urea nitrogen increase (mg/dL) >5 >2
Serum calcium (mg/dL) <8 <8
Arterial pO2 (mmHg) <60 NA
Serum base deﬁcit (mEq/L) >4 >5
Fluid sequestration (L) >6 >4
Table 4 BISAP Scoring System7
BUN > 25 mg/dL
Impaired mental status (Glasgow Coma Scale < 15)
SIRS: two or more of the following
Temperature < 36C or >38C
Respiratory rate > 20 breaths/min or PaCO2 < 32 mmHg
Pulse > 90 beats/min
White blood cells < 4000 or >12,000 cells/mm3 or >10% immature bands
Age > 60 years
Pleural effusion
Fig. 1. Axial CT image of interstitial edematous pancreatitis in a 56-year-old man after
endoscopic retrograde cholangiopancreatography. Amylase 4650 U/L, lipase > 396 U/L.
The image shows homogeneous enhancement of the pancreatic parenchyma (white
arrow) without necrosis and mild peripancreatic stranding.
Gastrointestinal Intervention 2013 2(1), 36–4638necrotizing pancreatitis. The main distinguishing factor among the
two is the presence or absence of necrosis. The detection and
classiﬁcation of necrosis in pancreatitis are of particular importance
because mortality of up to 23% is seen in patients with necrotizing
pancreatitis and life-threatening complications almost all occur in
patients with necrosis. In addition, patients with necrotizing
pancreatitis are much more likely to suffer from secondary infect-
tion.14 Image description and classiﬁcation are also determined by
whether imaging is performed early (<4 weeks from time of onset)
or later (>4 weeks; Table 5).11,12
In patients with acute IEP, CT typically reveals an enlarged
pancreas. The parenchymal enhancement is generally normal
(homogeneous throughout) or with minimal heterogeneity,
reﬂecting edema within the gland. Early on, the peripancreatic
tissues may appear normal or show inﬂammatory changes such as
ground-glass opacity and stranding within the peripancreatic fat
(Fig. 1). There may also be varying amounts of peripancreatic ﬂuid.
At <4 weeks, these ﬂuid collections are termed acute peripancre-
atic ﬂuid collections (APFCs) and purely comprise ﬂuid contents (no
solid or non-ﬂuid components). They are often the result of leakage
of pancreatic enzymes from a ruptured side-branch duct, show no
discernible wall, and typically respect the anatomic and fascial
boundaries of the retroperitoneum (Fig. 2). The vast majority of
these collections are spontaneously resorbed within the ﬁrst few
weeks after onset of pancreatitis.
After 4 weeks, approximately 10–20% of patients with IEP and
APFCs can develop pseudocysts as a complication of acute
pancreatitis.12 Pseudocysts are identiﬁed on CT by the presence of
an identiﬁable, smooth, and uniform wall. Pseudocysts are also
typically round or oval and, depending on their size, may exert a
mass effect on adjacent structures rather than insinuate along tis-
sue planes, as observed for APFCs (Fig. 3). Like APFCs, pseudocysts
have purely ﬂuid contents and may maintain a connection to the
pancreatic ducts, resulting in amylase- and lipase-rich ﬂuid. Once a
pseudocyst seals off, it often spontaneously vanishes, as revealed by
follow-up imaging.
Secondary infection of pseudocysts is rare but can occur and is
often manifest as gas bubbles within the pseudocyst on CT,
although this is not always the case. If the patient displays signs andTable 5 Revised Atlanta Classiﬁcation for Imaging11,12
Pancreatitis Collection Infection
<4 wk
IEP APFC Infection
Necrotizing pancreatitis PNPFC
Parenchymal necrosis Infection
Peripancreatic necrosis
Mixed necrosis
>4 wk
IEP Pseudocyst Infection
Necrotizing pancreatitis WOPN Infection
APFC, acute peripancreatic ﬂuid collection; IEP, interstitial edematous pancreatitis;
PNPFC, post-necrotic pancreatic ﬂuid collection; WOPN, walled-off pancreatic
necrosis.symptoms of infection, ﬁne needle aspiration (FNA) of the cyst for
Gram staining and culture may be required for a diagnosis. Even
less common than pseudocyst infection is the occurrence of sec-
ondary infection in patients with IEP and APFCs. In a retrospective
series to evaluate complications and ﬂuid collections in patients
with acute mild pancreatitis, Lenhart and Balthazar found no
complications at all in patients without peripancreatic ﬂuid col-
lections (IEP without APFC).15
If evidence of necrosis is detected on CECT, then the patient is
categorized as having necrotizing pancreatitis. This category is
further subdivided according to the Atlanta classiﬁcation based on
the location of the necrosis, which in the ﬁrst 4 weeks is termed
post-necrotic pancreatic ﬂuid collection (PNPFC), also sometimes
referred to as acute necrotic collection (ANC). Acute necrotizing
pancreatitis can involve (1) parenchymal necrosis alone, (2) peri-
pancreatic necrosis alone, or (3) mixed parenchymal and peri-
pancreatic necrosis.
Pancreatic parenchymal necrosis alone is relatively uncommon
in comparison to the other two forms of necrotizing pancreatitis,
accounting for only 5% of cases (Fig. 4). On CECT, parenchymal
necrosis appears as an area of glandular non-enhancement. The
degree of homogeneity in the area of necrosis varies on a contin-
uum, as liquefaction of the necrotic material progresses over time.
The extent of parenchymal necrosis is approximated as <30%, 30–
50% or >50% of the gland, although estimates of <30% are less
reliable and follow-up imaging in 5–7 days is sometimes necessary
to conﬁrm true necrosis versus glandular edema, as seen in IEP.11,12
Isolated peripancreatic necrosis in the absence of parenchymal
necrosis is seen in up to 20% of cases. This can be more difﬁcult to
diagnose on CT alone, but inhomogeneous ﬂuid collections in the
peripancreatic spaces and in the lesser sac, and thickening and
inﬂammatory changes at the root of the small bowel mesentery
provide clues for diagnosis. These patients typically have a better
prognosis than patients with other types of necrotizing pancreatitis
owing to preservation of the gland itself.11
By far the most common form is mixed parenchymal and peri-
pancreatic necrosis, which is seen in 75–80% of cases of acute
necrotizing pancreatitis (Fig. 5). PNPFCs (seen <4 weeks from
onset) have a variable appearance as the composition of the
collection changes with progressive liquefaction of necrotic mate-
rial. PNPFCs can sometime be difﬁcult to distinguish from APFCs,
especially within the ﬁrst week after diagnosis, and MRI (or occa-
sionally US) can be useful to visualize the debris and complexity in
Fig. 2. Axial CT images in a 48-year-old female with interstitial edematous pancreatitis and acute peripancreatic ﬂuid collections. The gland is edematous but enhanced throughout.
There is no evidence of necrosis. Homogeneous ﬂuid collections in the mesentery (white arrow) have no discernible wall and no solid or non-ﬂuid components. Amylase 244 U/L,
lipase > 396 U/L.
Fig. 3. (A) Axial contrast-enhanced CT (CECT) for a 51-year-old man. (B) T2-weighted MRI for a 48-year-old female. Both show pseudocysts. CECT demonstrates a round, well-
circumscribed ﬂuid collection adjacent to the pancreatic tail, with a thin but discernible enhanced wall (white arrow). T2 MRI shows a round ﬂuid collection with a thick wall
(black arrow). There is no evidence of solid or non-ﬂuid contents.
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breakdown of the pancreatic architecture, PNPFCs may often
maintain communication with the main or side-branch pancreatic
ducts. MRI can also be useful for delineating this connection.
After approximately 4 weeks, if the necrotic collections are no
resorbed, the necrosis can mature and develop a thick wall, termed
walled-off pancreatic necrosis (WOPN) (Fig. 7). DistinguishingFig. 4. Axial CT images showing isolated parenchymal necrosis in a 48-year-old male
with necrotizing pancreatitis. There is no enhancement of the pancreatic body and tail
(>50% of the gland; white arrow) and relative sparing of the pancreatic head (black
arrow). There are peripancreatic inﬂammatory changes, with thickening of Gerota’s
fascia and of the left paracolic gutter.WOPN from pseudocysts is important, as management strategies
differ for these two types of collections. Both PNPFCs and WOPNs
can become infected. This is suggested by the presence of gas
within the necrotic collections or extraluminal gas bubbles,
although perforation or ﬁstular communication with the gastro-
intestinal tract should be excluded as a source of gas within the
collection. As with pseudocysts, if no gas is seen but there is otherFig. 5. Axial CT image for a 62-year-old male with acute necrotizing pancreatitis with
mixed parenchymal and peripancreatic necrosis. Multifocal areas of nonenhancement
within the gland parenchyma (white arrow) and peripancreatic ﬂuid collection are
present, along with enhancement and thickening of Gerota’s fascia (black arrow).
Fig. 6. (A) Axial T2-weighted and (B) T1 post-contrast MR images for a 53-year-old male with necrotizing pancreatitis demonstrate a necrotic ﬂuid collection (white arrows). The
ﬂuid collection has an enhanced wall with irregular, non-ﬂuid components.
Gastrointestinal Intervention 2013 2(1), 36–4640clinical evidence of infection, FNA for Gram staining and culture
should be performed (Fig. 8).11,12
Other CTgrading systems have been developed over the last two
decades to further reﬁne patient prognosis and quantify morbidity
and mortality rates. Most notable is the CT severity index proposed
by Balthazar et al in 1990.16 This allows radiologists to grade the
severity of pancreatitis on a 10-point scale, with points allotted for
the amount of peripancreatic inﬂammation and ﬂuid collections, as
well as the amount of pancreatic necrosis (<30%, 30–50%, or>50%).
This was followed in 2004 by a modiﬁed CT severity index designed
by Mortele et al that incorporates extrapancreatic complications in
the scoring system and simpliﬁes analysis of the degree of
pancreatic necrosis (<30% or >30%) (Table 6).17
MRI of the pancreas and MR cholangiopancreatography (MRCP)
have been increasingly used to evaluate patients with acute
pancreatitis. MRI has a distinct advantage over CT: it does not use
ionizing radiation, which is important, particularly for younger
patients requiring multiple follow-up exams or with recurrent
disease. In addition, MRI/MRCP is superior to CT for evaluation of
choledocholithiasis and the pancreatic ductal system. It is also
important as an adjunct to CECT for evaluating the contents of
pancreatic and peripancreatic collections to help distinguish
necrotic collections (PNPFCs and WOPNs) from non-necrotic col-
lections (APFCs and pseudocysts).11,12 In patients older than 40
years for whom no cause of pancreatitis has been identiﬁed, MRI
can be especially useful in searching for underlying occult neo-
plasms as a cause of pancreatitis. Drawbacks of MRI include its
relatively high cost and its impracticality for critically ill patientsFig. 7. Axial CT images of 48-year-old male with necrotizing pancreatitis taken
approximately 5 weeks after the image in Fig. 4 shows walled-off pancreatic necrosis
involving the necrotic portion of the pancreatic body and tail (white arrow).who are unable to tolerate long imaging times or effectively hold
their breath for many sequences.18
Both CECT and MRI are useful in the detection of other extrap-
ancreatic complications of acute pancreatitis, including venous
thrombosis, gastric varices, pseudoaneurysm formation and
rupture, hemorrhage, ascites, ﬁstulization and rupture of the GI
tract, and pleural effusion.
Medical management of acute pancreatitis
Initial assessment of the severity of acute pancreatitis is the
cornerstone in determining further medical management.
Aggressive intravenous ﬂuid replacement is very important to treat
ﬂuid losses caused by third space shifts, vomiting, diaphoresis, and
increased vascular permeability caused by inﬂammatory media-
tors. Clinically, the adequacy of ﬂuid resuscitation should be
monitored in terms of vital signs, urinary output, and hematocrit at
12 and 24 hours after admission (particularly for patients with
hemoconcentration on admission).8 A second important conse-
quence of hypovolemia is intestinal ischemia. Ischemia increases
intestinal permeability to bacteria and endotoxins, an important
cause of secondary pancreatic infection.1
Adequate pain management with opiate analgesics is important
for treatment of severe pain associated with acute pancreatitis.
Patient-controlled analgesia is often helpful for good pain control.
However, monitoring of oxygenation while on high-dose opiate
medications is necessary. According to current American College of
Gastroenterology guidelines, initial routine oxygen delivery via aFig. 8. Axial contrast-enhanced CT image for a 53-year-old male with necrotizing
pancreatitis showing infected walled-off necrosis as evidenced by gas within the
collection (white arrow).
Table 6 CT Severity Index and Modiﬁed CT Severity Index16,17
CT severity index Modiﬁed CT severity index
Prognostic indicator Points Prognostic indicator Points
Pancreatic inﬂammation Pancreatic inﬂammation
Normal pancreas 0 Normal pancreas 0
Enlargement of pancreas 1 Pancreatic abnormalities
with or without peripancreatic
inﬂammation
2
Pancreatic abnormalities
with peripancreatic
inﬂammation
2 Pancreatic or peripancreatic
ﬂuid collection or fat necrosis
4
Single ﬂuid collection 3
Two or more
collections or gas
4
Pancreatic necrosis Pancreatic necrosis
None 0 None 0
<30% 2 <30% 2
30–50% 4 >30% 4
>50% 6
Extrapancreatic complications
(pleural effusion, ascites,
parenchymal complications,
GI tract involvement)
2
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pancreatitis.1
Nutritional support should be considered when patients are
unlikely to be able to eat for 7 days. To compare the safety and
clinical outcomes of enteral and parenteral nutrition in patients
with acute pancreatitis, a meta analysis of six studies conducted in
2004 revealed that enteral nutrition was associated with a signiﬁ-
cantly lower incidence of infections (relative risk 0.45; 95% conﬁ-
dence interval 0.26–0.78, P¼ 0.004), fewer surgical interventions to
control pancreatitis (0.48, 0.22–1.0, P ¼ 0.05), and shorter hospital
stays (mean reduction 2.9 days, range 1.6–4.3 days, P < 0.001).
However, there was no signiﬁcant difference in mortality (relative
risk 0.66, 0.32–1.37, P ¼ 0.3).19
The use of prophylactic antibiotics to prevent pancreatic infection
is not recommended for patients with necrotizing pancreatitis.1 This
guideline isbasedon two randomizedstudies, the latterofwhichwas
a multicenter, prospective, double-blind, placebo-controlled study
conducted in32 centers inNorthAmerica andEurope.20,21 Pancreatic
or peripancreatic infection developed in 18% (9 of 50) of patients in
the group treated with meropenem, compared with 12% (6 of 50) of
patients taking placebo (P ¼ 0.401). The overall mortality rate was
20% (10 of 50) in the meropenem group and 18% (9 of 50) in the
placebo group (P¼ 0.799). Surgical interventionwas required in 26%
(13 of 50) of the patients takingmeropenemand20% (10 of 50) of the
patients taking placebo (P ¼ 0.476). This study demonstrated no
signiﬁcantdifferencesbetween the treatmentandplacebogroups for
pancreatic or peripancreatic infection, mortality, or requirement forFig. 9. Fine needle aspiration (FNA) of peripancreatic ﬂuid collections. Several peripancreat
female patient with complicated acute pancreatitis and sepsis. FNA of different ﬂuid collectsurgical intervention, and therefore did not support early prophy-
lactic antimicrobial use in patients with severe acute necrotizing
pancreatitis.21
Radiologic intervention
The role of interventional radiology in the management of acute
pancreatitis complications falls into two main categories.Percutaneous drainage of peripancreatic ﬂuid collections in IEP
Peripancreatic ﬂuid collections develop in the early phase of
acute pancreatitis within or around the pancreas in approximately
40% of cases.3 These can be found in the peritoneal and retroperi-
toneal spaces and less frequently in the mediastinum. Early in the
course of the disease (<4 weeks), the APFCs do not have deﬁnite
epithelial walls and boundaries are limited by the natural fascial
barriers of the retroperitoneum and peritoneum. In most cases,
spontaneous resolution occurs without intervention. If APFCs
do not resolve spontaneously and persist beyond 4 weeks to
develop an identiﬁable wall and become pseudocysts, approxi-
mately 25% can cause a spectrum of symptoms mostly related to
mass effects.12 Pseudocysts can also become infected, necessitating
treatment.22–24
Intervention for both APFCs and pseudocysts is indicated for
infected collections or when they cause severe symptoms.25,26
However, neither clinical nor radiological signs are highly speciﬁc
for the diagnosis of infected collection contents, and therefore FNA
with subsequent microbiological analysis remains the gold stan-
dard to conﬁrm the presence of underlying infection.27 Pancreatic
necrosis and ﬂuid collections can be aspirated using either CT or US
guidance and samples are collected under sterile conditions to
evaluate underlying infection (Fig. 9). The size of the aspiration
needle required depends on the viscosity and thickness of the
aspirated material but usually varies between 22 and 18 gauge.
False negative rates for aspiration to diagnose or conﬁrm infection
are very low (<10%) and repeat FNA should be performed if there is
persistent clinical suspicion of infection in the face of a negative
result.12
Percutaneous drainage of peripancreatic collections is a well
established and common procedure and simple drainage will often
sufﬁce for these collections. The drainage catheter is predominantly
placed under CT guidance and to a lesser extent under US guidance.
Strict sterility is maintained and local anesthesia is applied. For
both diagnostic aspiration and therapeutic drainage, a retroperi-
toneal approach is preferred over an anterior transperitoneal
approach, if possible.12 Moderate conscious sedation or general
anesthesia can be used, as the clinical situation demands.ic ﬂuid collections were seen on a CT scan of the abdomen and pelvis in a 56-year-old
ions (white cursors) was performed to localize the infected collections or pseudocysts.
Gastrointestinal Intervention 2013 2(1), 36–4642Two different image-guided techniques are used for drainage
catheter insertion. The Seldinger technique, named after the
Swedish radiologist Sven-Ivar Seldinger, consists of advancing an
18-gauge needle into the target collection under CT or US guidance.
A 0.035-inch guide wire is advanced through the needle, and the
needle is exchanged for the catheter over the wire and secured in
the drained collection (Fig. 10). Alternatively, the tandem-trocar
technique involves similar initial access to the collection via a
smaller needle (20–22 gauge) (Fig. 11). Then a trocar-loaded cath-
eter is advanced along a parallel trajectory to a measured depth and
a pigtail tip is formed in the cavity. The collection can also be
accessed using combined US and ﬂuoroscopic guidance. After ac-
cess is obtained and conﬁrmed by US, contrast injection under
ﬂuoroscopy can be performed to evaluate the extent of the collec-
tion and elucidate any ﬁstulous connection to the main pancreatic
duct or adjacent bowel. The needle can then be exchanged over a
wire for the drainage catheter under ﬂuoroscopic guidance.
After initial access to the collection using either technique,
samples are routinely aspirated for analysis, regardless of the de-
gree of suspicion of infection. Drainage catheters typically remain
in place until the drained ﬂuid is clear and <10–30 mL per day.
Follow-up imaging to conﬁrm drainage catheter position and
document collection resolution is often necessary.
Percutaneous drainage of PNPFC and WOPN
Acute necrotizing pancreatitis accounts for 10–15% of all cases of
acute pancreatitis and can be complicated by infected necrosis and
multisystem organ failure.1,28 On CECT, WOPN can be misdiagnosed
as a pseudocyst and unsuccessfully managed by conventional
percutaneous drainage. MRI plays a crucial role in the correct
diagnosis of WOPN since it provides better appreciation of the
amount of ﬂuid and non-liquid necrosis in the collection, resultingFig. 10. Seldinger technique in a 37-year-old male patient with necrotizing acute pancreatit
the target cavity (white arrow). A 0.035 guide wire was advanced through the needle until it
a 10 French multipurpose drainage catheter was advanced over the guide wire.
Fig. 11. Tandem trocar technique in a 60-year-old female patient with a retrogastric lesser
needle. After the position of the needle tip was conﬁrmed inside the pseudocyst, a 10 Fre
measured depth and a pigtail formed within the pseudocyst.in appropriate management.18 Management of necrotizing
pancreatitis has evolved over the past two decades from more
aggressive and traditional surgical necrosectomy to more conser-
vative management relying on minimally invasive percutaneous
and endoscopic necrosectomy. This change was prompted by
higher mortality in patients who underwent early surgical
necrosectomy compared to patients with delayed surgery per-
formed more than 28 days following the onset of symptoms.29,30
The percutaneous drainage and necrosectomy procedure is per-
formed using the same techniques as for conventional intra-
abdominal collection drainage, as discussed above. However,
double-sump large-bore catheters of up to 30 French are used for
better evacuation of the necrotic debris. Initially the catheters are
irrigated using up to 1.5 L of sterile normal saline per drain daily,
depending on the size of the collection.31 The clinical success of
percutaneous necrosectomy varies from 20% to 64%.31,32 An alter-
native nonsurgical method for treatment of WOPN is endoscopic
necrosectomy and drainage.
Complications related to percutaneous drainage such as injury
of the surrounding organs and bleeding are rare (2%). More
commonly, the drain can become clogged or dislodged, requiring
replacement. A late complication of percutaneous drainage is the
development of pancreatic ﬁstulae to the skin or gastrointestinal
tract, but most close spontaneously.Endoscopic and surgical intervention
Indication and timing of ERCP for gallstone pancreatitis
Several studies investigated the effect of early ERCP in acute
biliary pancreatitis. Neoptolemos et al found that ERCP within 72
hours decreased morbidity in patients with severe pancreatitisis. (A,B) The tip of a 15-cm-long 18-gauge needle was advanced under CT guidance into
s ﬂoppy tip was coiled within the cavity (black arrow). (C) The needle was removed and
sac pseudocyst. Initial access into the cyst was gained using a 15-cm-long 20-gauge
nch multipurpose drainage catheter was advanced in tandem with the needle to the
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early ERCP in patients with mild acute pancreatitis. Fan et al
showed that ERCP within 24 hours in patients with acute severe
pancreatitis decreased the incidence of biliary sepsis. Survival
beneﬁt of early ERCP was also seen in patients with acute pancre-
atitis if biliary sepsis was present.34 Folsch et al excluded jaundiced
patients and focused on the role of early ERCP in patients with
severe acute pancreatitis in the absence of cholangitis and found no
beneﬁt of early ERCP.35 According to the American Society for
Gastrointestinal Endoscopy (ASGE) guidelines, there is no role for
early ERCP in the evaluation andmanagement of patients withmild
acute pancreatitis in the absence of clear evidence of a retained
stone. Conversely, in patients with acute pancreatitis and
concomitant cholangitis, early ERCP (within 24–72 hours) is
strongly recommended.36
Indication and timing of cholecystectomy for gallstone pancreatitis
For both open and laparoscopic cholecystectomy there has been
debate about the best timing of cholecystectomy after an episode of
gallstone pancreatitis. There is now a consensus that cholecystec-
tomy should be delayed until the clinical symptoms of acute
pancreatitis subside, but not so long that a second attack occurs, for
the best clinical outcome. In milder cases of acute pancreatitis, it is
not clear if surgery needs to be delayed until amylase and lipase
levels have normalized, or even until all abdominal pain has gone.
Many clinicians and clinical systems advocate that patients hospi-
talized with an attack of acute gallstone pancreatitis undergo a
cholecystectomy once they have clinically recovered but prior to
hospital discharge since the likelihood of a subsequent attack is
approximately 30% over the next 3 months. It is clear that endo-
scopic sphincterotomy also substantially reduces the likelihood of
subsequent attacks of gallstone pancreatitis, probably to the same
degree as cholecystectomy does. However, sphincterotomy does
not eliminate the risk of subsequent cholecystitis and has its own
suite of procedural complications. Consequently, laparoscopic
cholecystectomy is currently considered the default procedure to
prevent subsequent attacks in mild or moderate acute gallstone
pancreatitis, while endoscopic sphincterotomy is an alternative
procedure typically chosen for reasons speciﬁc to an individual
patient to achieve the same end.
Endoscopic management of pancreatic ﬂuid collection
Endoscopic transmural drainage of pancreatic ﬂuid collections is
a form of natural oriﬁce transluminal endoscopic surgery (NOTES),
which is minimally invasive and has high success rates. It has been
used for drainage of pseudocysts, pancreatic abscesses, and necrosis.
Indications and criteria for endoscopic drainage include pseu-
docysts with symptoms such as pain andmechanical obstruction of
the gastric outlet or biliary system. Drainage of enlarging pseudo-
cysts that do not resolve after 6 weeks is also indicated to prevent
subsequent complications such as hemorrhage, perforation, or
secondary infection. Pancreatic abscesses and infected necrosis also
require drainage for effective control of infection and sepsis.
The ﬁrst endoscopic drainage of pancreatic necrosis was per-
formed in 1995.37 Since then the technique has been modiﬁed from
an irrigation approach to direct endoscopic debridement or
necrosectomy in 2000.38 Endoscopic necrosectomy is typically
performed at least 3–4 weeks after the onset of pancreatic necrosis.
This allows for encapsulation and demarcation of peripancreatic
collections, known as WOPN, thereby decreasing the risk of
bleeding and perforation. Treatment is performed in a multi-stage
procedure involving cystgastrostomy followed by repeated
necrosectomy sessions. Cystgastrostomy is the ﬁrst step, where aﬁstula tract is created between the collection of pancreatic necrosis
and the gastric wall. Endoscopic US is used to locate the collection,
which is then accessed by puncturing through the gastric wall,
followed by balloon dilatation of the tract (Fig. 12). Two or more
double pigtail stents are then placed into the tract for continual
drainage. More recently, a new fully covered self-expandable metal
stent has been used successfully in infectedWOPN.39 Necrosectomy
is then typically performed 2–4 weeks after cystgastrostomy. Dur-
ing necrosectomy, the endoscope is advanced through the tract into
the necrotic cavity and repeated removal of necrotic tissue is per-
formed (Fig. 13). Double pigtail stents are inserted into the tract at
the end of the procedure. Multiple sessions are typically required
for complete resolution of the necrotic collection. More recently,
the creation of two or three transmural tracts between the necrotic
cavity and the GI lumen using endoscopic US (EUS) guidance yiel-
ded encouraging initial results.40 Treatment was successful in 92%
of the 12 patients who underwent this multiple transluminal
gateway technique compared to 52% in 48 patients treated with
conventional one-tract drainage.
Outcomes of endoscopic necrosectomy have been investigated
in multiple recent studies. In the multicenter GEPARD study, 93
patients underwent a mean of six endoscopic necrosectomy ses-
sions, starting at a mean of 43 days after an attack of severe acute
pancreatitis. Repeated sessions were performed at intervals of 1–4
days until all necrotic material had been removed. The success rate
was 81%, with 84% of those successfully treated surviving without
recurrence at a mean follow-up of 43 months. The mortality rate
was 7.5% at 30 days. Major complications occurred in 26% patients,
including bleeding, perforation of necrosis into the abdominal
cavity, ﬁstula formation, and air embolism (which is caused by
prolonged procedures, and can be minimized using CO2 for insuf-
ﬂation).41 In another large multicenter retrospective series in the
USA, endoscopic necrosectomy was successful in 91% of 104 pa-
tients. A median of three procedures with two debridements were
performed, with the ﬁrst debridement performed at a mean of 63
days after the initial onset of acute pancreatitis. The mean time to
resolution from the initial procedure was 4.1 months. Complica-
tions occurred in 14%, with ﬁve perforations or pneumoperitoneum
that were managed nonoperatively. A high BMI of >32 was iden-
tiﬁed as a risk factor for failure of endoscopic necrosectomy.42 In a
systematic review of 10 studies with 260 patients with pancreatic
necrosis, resolution of necrotic ﬂuid collections by endoscopic
intervention alone was achieved in 76% after an average of four
endoscopic sessions. The overall mortality for endoscopic
necrosectomy was 5% and the mean procedure-related morbidity
rate was 27%. Bleeding was the most common complication, fol-
lowed by exacerbation of sepsis and perforation.43 In another large
retrospective study of 211 patients who underwent endoscopic
transmural drainage of peripancreatic ﬂuid (45% pseudocyst, 28%
abscess, 27% necrosis), overall treatment success with complete
resolution or decrease in size of the pancreatic ﬂuid collection to
2 cm was 85%. The procedure was more successful for patients
with a pseudocyst or abscess than for those with necrosis (93% vs.
63%). Complications were seen in 16% of the necrosis cases versus
5% of the patients with a pseudocyst or abscess, and included
infection, perforation, bleeding, and stent migration.44
Surgical management of complications of acute pancreatitis
The indication for surgery in acute pancreatitis is best described
as management of speciﬁc complications of acute pancreatitis.
These complications almost always occur in patients with severe or
necrotizing pancreatitis, typically more than 10 days from the onset
of the attack and sometimes more than 3 months later. However,
some complications can occur early in the course of severe acute
Fig. 12. (A) Endoscopic ultrasound (EUS)-guided needle access into necrotic pancreatic ﬂuid collection (white arrow). (B) Fluoroscopic image of balloon dilation of the cystgas-
trectomy tract (black arrow).
Gastrointestinal Intervention 2013 2(1), 36–4644pancreatitis, such as abdominal compartment syndrome, requiring
emergency decompressive laparotomy and an open abdomen in
the intensive care unit. In addition, infarction of the transverse
colon caused by inﬂammatory thrombosis of the mesocolic vessels
requires emergency colon resection and colostomy.
Strictures of the bile ducts, duodenum, or other segments of the
bowel caused by chronic scarring are managedwith surgical bypass
or resection. This typically occurs many months after the acute
attack. Bleeding from a ruptured pseudoaneurysm or GI bleeding
secondary to portal gastropathy or esophageal varices due to
thrombosis of the splenic vein are complications that tend to occur
later in the course of acute severe necrotizing pancreatitis and may
require surgical management. However, interventional vascular
techniques using embolization and sometimes stents are often
better ﬁrst management choices for these problems. This is espe-
cially true for unstable patients since the surgery to access the
bleeding site or resect the spleen to manage sinistral portal hy-
pertension can be prolonged and arduous.
It is well established that acute pseudocysts and ﬂuid collections
are best managed by expectant observation since they mostly
resolve on their own. Larger cysts that persist for more than 6
weeks and are symptomatic beneﬁt from internal drainage into the
gut. Traditionally, this has been accomplished by an open surgical
cystgastrostomy, cystduodenostomy, or Roux Y cystjejunostomy,Fig. 13. Removal of necrotic debris during necrosectomy.depending on the location of the cyst. These operations are effec-
tive at producing symptom relief and preventing recurrence. They
are now often accomplished laparoscopically when surgery is
required. However, internal drainage of these cysts is far more
commonly managed by endoscopic stenting of either the pancre-
atic duct or through the stomach wall into the cyst, or both, as
discussed previously. These maneuvers are certainly quicker and
less invasive than open surgery, although it is not clear whether
they are as cost effective, and vascular structures in the wall of a
cyst may inhibit the ability of the endoscopist to safely place a stent
or pigtail drain into the cyst. Occasionally, a cyst is surgically
resected as deﬁnitive management of symptoms, usually when
there are no good drainage options or if there are concerns that the
cyst may be neoplastic rather than a pseudocyst. Infected cysts that
require treatment early in the course of pancreatitis are best
drained externally by image-guided radiologic interventions rather
than surgical approaches.
The problem with any collection drainage procedure in this
setting is the amount of necrotic debris in the collection. When
there is only a small amount of necrotic debris within the cyst and a
large volume of ﬂuid, drainage procedures are quite effective.
When the ﬂuid collection consists mostly of gelatinous, semisolid,
necrotic debris, it often will not drain successfully by internal or
external methods. Over the past 30 years, mechanical surgical
debridement of this pancreatic necrosis has been the mainstay
treatment and has dramatically improved what was previously the
lethal natural history of this condition. The tactics and tools used
for surgical debridement have steadily evolved, and outcomes
measured as conventional morbidity and mortality have also
steadily improved. The surgery for this condition was originally
open, with sequential trips to the operating theater every second or
third day for debridement with gauze packing of the cavity to aid
both debridement and hemostasis. This process required prolonged
stays in the intensive care unit (ICU) and was associated with
multiple complications related to the sequelae of severe pancrea-
titis and repeat surgery (e.g., enterocutaneous ﬁstulae, iatrogenic
bleeding and vascular injury, hernias) and ICU support (e.g.,
ventilator-associated pneumonia, line infections). Early contro-
versies revolved around whether outcomes could be improved by
debridement of the necrosis earlier in the course of severe acute
necrotizing pancreatitis. Several small trials demonstrated quite
clearly that earlier compared to delayed debridement of pancreatic
necrosis was associated with much poorer survival outcomes. The
reasons for the adverse outcomes associated with early
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separating necrotic tissue from surrounding inﬂamed and highly
vascularized tissue. With delay, the necrotic tissue becomes more
demarcated, has less vascular adhesion to the surrounding viable
tissue, and can be debridedmuchmore easily with blunt dissection.
In patients for whom debridement could be delayed, it became
clear that a single open operative debridement with the use of
multiple drains could resolve the condition most of the time,
although repeat operative debridements or subsequent interven-
tional radiologic drains were still required in approximately 20% of
these patients.
Endoscopic versus surgical necrosectomy
In the 2010 randomized PANTER trial (Pancreatitis, Necrosec-
tomy vs. Step-up Approach), the Dutch Pancreatitis Study Group
noted that a stepped-up approach involving percutaneous catheter
drainage and subsequent minimally invasive surgical necrosectomy
was superior to primary open necrosectomy, with signiﬁcantly
fewer complications.45 In addition, 35% patients were adequately
treated with percutaneous drainage alone.
In the more recent randomized PENGUIN trial (Pancreatitis,
Endoscopic Transgastric vs. Primary Necrosectomy in Patients with
Infected Necrosis), the Dutch Pancreatitis Study Group compared
endoscopic necrosectomy (n ¼ 10) with surgical necrosectomy
(n ¼ 10) using video-assisted retroperitoneal debridement (n ¼ 6)
or laparotomy (n ¼ 4).46 Serum levels of the proinﬂammatory
cytokine IL-6 were lower for the endoscopic compared to the sur-
gical approach. The endoscopic approach also resulted in lower
rates of new-onset multiorgan failure (0% vs. 50%), ﬁstula formation
(10% vs. 70%), and mortality (10% vs. 40%).
Integrated management approach for pancreatitis necrosis
A major distinction was drawn between the natural history of
sterile and infected pancreatic necrosis, and signiﬁcant diagnostic
efforts (e.g. image-guided FNA of the necrosis) have been used to
distinguish between them. It was believed that urgent surgery was
required for all patients with infected necrosis whereas patients
with sterile necrosis could bemanaged expectantly. However, it has
been found that many patients with persistently symptomatic
sterile pancreatic necrosis can also beneﬁt from debridement.
Furthermore, the pre-debridement diagnosis of sterile necrosis was
incorrect 70% of the time. More importantly, management of
infected necrosis has evolved through the integration of other
interventional techniques. It is now clear that a graduated or
stepped-up approach using antibiotics and multiple drains can
bridge critically ill patients to more optimal physiological condi-
tions and optimize the timing for mechanical debridement of
infected necrosis. Surgical intervention has also become less inva-
sive with the adaptation of laparoscopic techniques to access and
debride the necrotic debris.
There are currently two laparoscopic approaches: the standard
transabdominal technique via a pneumoperitoneum and the so-
called retroperitoneal approach in which percutaneous drain
tracts to the cavity are dilated and used to place trocars and in-
struments into the necrotic cavity. Although a properly timed,
single open debridement may deﬁne the standard for outcomes in
this condition, morbidity and mortality appear to be signiﬁcantly
improved by a stepped-up approach compared to proceeding
straight to a more deﬁnitive open debridement.
One of the complications that can follow any of these operative
debridement techniques for pancreatic necrosis is a pancreatic
ﬁstula from a viable pancreas segment disconnected from the main
pancreatic duct. This problem is often surgical; requiring anotheroperation to achieve internal drainage of the ﬁstula into the in-
testine. This problem does not occur after transgastric endoscopic
debridement since an internal drainage route for any disconnected
pancreatic segment is a byproduct of the method for accessing the
necrotic cavity. In addition, incorporation of transgastric endo-
scopic debridement in a stepped-up approach to pancreatic ne-
crosis appears to yield improved morbidity and mortality
compared to a stepped-up approach using laparoscopic debride-
ment. Open surgical debridement may still be occasionally neces-
sary for patients with fulminant infected pancreatic necrosis
unresponsive to less invasive maneuvers and occurring earlier in
the course of severe necrotizing pancreatitis before the necrotic
tissue is clearly demarcated. However, patients whose infected
pancreatic necrosis can be managed by a stepped-up approach
should probably undergo debridement by transgastric endoscopic
techniques if local expertise exists and the necrotic cavity can be
accessed in this way.
Conclusion
Many diagnostic and treatment options are available for acute
pancreatitis. However, astute evaluation of the patient on presen-
tation is vital for appropriate initial management of the disease.
Likewise, both the timing and interpretation of imaging will
signiﬁcantly impact the patient triage. The Atlanta classiﬁcation of
1992 and its subsequent revision in 2008 were devised to create a
standardized radiographic lexicon to better classify patients ac-
cording to the type of acute pancreatitis and characterize associated
ﬂuid collection and necrosis. This in turn can better direct treat-
ment options, whether percutaneous drainage by intervention
radiology or endoscopic management versus surgical necrosec-
tomy. Overall, successful management of acute pancreatitis re-
quires a multidisciplinary approach with coordination of multiple
subspecialty services including diagnostic and interventional
radiology, gastroenterology, and surgery.
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